UnknownNot Applicable

Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage

South Korea9 participantsStarted 2016-01

Plain-language summary

This is a follow-up study of the open label, single-center, phase I clinical trial to evaluate the safety of Pneumostem® in premature infants with Intraventricular hemorrhage.

Who can participate

Age range6 Months – 2 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH. Exclusion Criteria: * Patients who did not enrolled in the previous phase 1 clinical trial of Pneumostem transplantation for IVH.

What they're measuring

newly developed brain tumor

Timeframe: until 2 years old (corrected age)

Trial details

NCT IDNCT02673788

SponsorSamsung Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12

View on ClinicalTrials.gov More Intracranial Hemorrhages trials